|
Name |
2-Ethyl-p-xylene
|
Molecular Formula | C10H14 | |
IUPAC Name* |
2-ethyl-1,4-dimethylbenzene
|
|
SMILES |
CCC1=C(C=CC(=C1)C)C
|
|
InChI |
InChI=1S/C10H14/c1-4-10-7-8(2)5-6-9(10)3/h5-7H,4H2,1-3H3
|
|
InChIKey |
AXIUBBVSOWPLDA-UHFFFAOYSA-N
|
|
Synonyms |
2-Ethyl-p-xylene; 1758-88-9; 2-ETHYL-1,4-DIMETHYLBENZENE; 1,4-Dimethyl-2-ethylbenzene; Benzene, 2-ethyl-1,4-dimethyl-; p-Xylene, 2-ethyl-; 2,5-Dimethylethylbenzene; 1-Ethyl-2,5-dimethylbenzene; NSC74186; EINECS 217-158-3; NSC 74186; 1,4-Dimethyl-2-ethyl benzene; 1,4-dimethyl-2-ethyl-benzene; DTXSID0061951; BAA75888; ZINC1699570; MFCD00059233; NSC-74186; AKOS016846194; DS-2976; CS-0206595; E0279; FT-0690895; T71937; A881547; Q63391958
|
|
CAS | 1758-88-9 | |
PubChem CID | 15653 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.22 | ALogp: | 3.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.55 |
Caco-2 Permeability: | -4.386 | MDCK Permeability: | 0.00002220 |
Pgp-inhibitor: | 0.039 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.155 |
30% Bioavailability (F30%): | 0.943 |
Blood-Brain-Barrier Penetration (BBB): | 0.915 | Plasma Protein Binding (PPB): | 93.67% |
Volume Distribution (VD): | 1.951 | Fu: | 5.52% |
CYP1A2-inhibitor: | 0.94 | CYP1A2-substrate: | 0.947 |
CYP2C19-inhibitor: | 0.768 | CYP2C19-substrate: | 0.853 |
CYP2C9-inhibitor: | 0.402 | CYP2C9-substrate: | 0.601 |
CYP2D6-inhibitor: | 0.73 | CYP2D6-substrate: | 0.917 |
CYP3A4-inhibitor: | 0.224 | CYP3A4-substrate: | 0.517 |
Clearance (CL): | 10.462 | Half-life (T1/2): | 0.436 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.057 |
Drug-inuced Liver Injury (DILI): | 0.096 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.157 |
Skin Sensitization: | 0.194 | Carcinogencity: | 0.336 |
Eye Corrosion: | 0.975 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.042 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000734 | 0.636 | D06GIP | 0.400 | ||||
ENC000180 | 0.594 | D05VIX | 0.364 | ||||
ENC000552 | 0.500 | D0X0RI | 0.319 | ||||
ENC000407 | 0.486 | D0S5LH | 0.283 | ||||
ENC000649 | 0.459 | D0X4RN | 0.281 | ||||
ENC000413 | 0.444 | D01PJR | 0.280 | ||||
ENC001744 | 0.442 | D0EL2O | 0.274 | ||||
ENC001026 | 0.436 | D02YYF | 0.265 | ||||
ENC000614 | 0.417 | D04YMH | 0.262 | ||||
ENC000239 | 0.400 | D0T3NY | 0.259 |